Breast augmentation surgery is the most commonly performed aesthetic plastic surgery procedure worldwide. 1 A total of 1,862,506 breast augmentations were performed in 2018, an increase of 6.1% compared to 2017. 2 Over 20,000 breast augmentations were performed in Australia alone.The demographic undergoing this procedure is usually fit and low risk with minor comorbidities. These patients do not require long-term hospitalization and do not want to spend excessive time in the hospital for financial reasons. The ambulatory nature of this procedure is beneficial to both parties due to its practicality and affordability. However, readmission following the same-day surgery can affect morbidity, cost, and satisfaction. 3 Pain is the most critical factor in hospital revisits and patient satisfaction. 4 Conventionally, patients have been treated with high opiate analgesics to ameliorate pain. 5,6 However, opiate analgesia can have significant side effects for patients, such as nausea, vomiting, ileus, sedation, addiction, increased hospital costs, and length of stay. 7 Reducing volumes of postoperative opiates allows faster ambulation and discharge postsurgery.Conversely, under controlled pain in the acute period can lead to prolonged hospital stays, development of chronic pain, increased readmissions, and decreased patient satisfaction. 3,[8][9][10] Therefore, a delicate balance exists in the postoperative management of patients' pain.Related Digital Media are available in the full-text version of the article on www.PRSGlobalOpen.com.